Progression in clinical application of cryopreserved vascular allografts in the treatment of abdominal aortic graft infection
10.3760/cma.j.cn112139-20210813-00375
- VernacularTitle:同种异体血管治疗腹主动脉移植物感染的临床应用进展
- Author:
Honglin ZU
1
;
Ju HE
Author Information
1. 天津市第一中心医院血管外科 300192
- Keywords:
Aorta,abdominal;
Prostheses and implants;
Infection;
Cryopreserved vascular allografts;
In situ replacement
- From:
Chinese Journal of Surgery
2021;59(12):1029-1032
- CountryChina
- Language:Chinese
-
Abstract:
Once an abdominal aortic graft infection occurs,it is often catastrophic associated without high morbidity and mortality.Standard surgical treatment includes removing infected grafts,arteries,and surrounding tissues,and revascularization of blood supply to organs and limbs. Extra-anatomical vascular bypass and in-situ reconstruction are the main surgical treatment methods,and many factors affect the prognosis of surgical treatment. So far,there are a variety of vascular grafts used to restore revascularization in clinical practice,mainly including rifampicin or silver-coated artificial blood vessels,autologous veins,cryopreserved allogeneic blood vessels,or bovine pericardium and other biological materials. There is no consensus on the selection of the best vascular graft. In recent years,clinical application studies have confirmed that the results of cryopreserved allogeneic blood vessels for the treatment of graft infectious diseases are acceptable,but the complications related to grafts should not be ignored. This article reviews the clinical application progress of cryopreserved allogeneic blood vessels for the treatment of abdominal aortic graft infection.
